Navigation Links
ASTRO and AAPM announce launch of RO-ILS: Radiation Oncology Incident Learning System
Date:6/19/2014

Fairfax, Va., June 19, 2014 The American Society for Radiation Oncology (ASTRO) and the American Association of Physicists in Medicine (AAPM) today announced the launch of RO-ILS: Radiation Oncology Incident Learning System, a new, national patient safety initiative to facilitate safer and higher quality radiation oncology care. Announced at a Congressional Briefing today in B-339 of the Rayburn House Office Building on Capitol Hill, and co-hosted by U.S. Representatives Frank Pallone, (D-N.J.) and Ed Whitfield (R-Ky.), ASTRO Chair Colleen A.F. Lawton, MD, FASTRO, and John E. Bayouth, PhD, president of AAPM, unveiled the details of RO-ILS. Comments and perspective were also provided by Jeffrey Brady, MD, MPH, director of the Center for Quality Improvement and Patient Safety at the Agency for Healthcare Research and Quality (AHRQ).

Leaders from ASTRO and AAPM have worked together to develop RO-ILS, an online portal that will allow radiation oncology centers to provide non-patient-specific data about the radiation therapy near-misses and safety incidents that have occurred at their facility in a secure, non-punitive environment. RO-ILS is the only medical specialty society-sponsored radiation oncology incident learning system within a federally recognized Patient Safety Organization (PSO), Clarity PSO. Data collected in RO-ILS will educate the radiation oncology community about how to improve safety and patient care. The RO-ILS platform will provide centers with the ability to track and to analyze their data through a secure online interface. There are no fees for radiation therapy centers to participate in RO-ILS. RO-ILS can be used as a stand-alone incident learning system or as a complement to an institution's existing system. A panel of experts chosen by ASTRO and AAPM, called the Radiation Oncology Healthcare Advisory Council (RO-HAC), will work with Clarity PSO, the independent PSO contracted to develop and to administer RO-ILS, to analyze the aggregate data and to inform radiation oncology safety procedures and processes, best practices, practice guidelines and/or recommendations.

"We are excited to partner with AAPM on the launch of RO-ILS, a centerpiece of ASTRO's Target Safely initiative that demonstrates our commitment to safe and high quality radiation oncology treatment," said Dr. Lawton, chair of ASTRO's Board of Directors. "The complex and highly specialized radiation care we deliver to cure cancers and to treat more than one million patients each year requires that we be continually vigilant to ensure the safety of our patients and our radiation oncology care team. We are grateful that Congress, through the Patient Safety and Quality Improvement Act of 2005, provides us with the necessary protections to use RO-ILS to gather invaluable patient safety information as we strive to provide the safest and highest quality radiation treatments. One error is too many, and learning from near-misses is crucial to averting errors."

"We take great pride in our integral role in the radiation oncology treatment process, and we are pleased to have developed RO-ILS with our ASTRO partners to promote the safe delivery of radiation therapy treatments," said Dr. Bayouth, president of AAPM. "RO-ILS is an exceptional endeavor that will provide enormous returns for our collective knowledge. The entire radiation oncology care team is devoted to the utmost accuracy and safety for the complex radiation therapy process. RO-ILS will support our achievement of these critical goals."

"I applaud ASTRO and AAPM for their leadership in creating RO-ILS to safeguard radiation therapy care, and it is particularly meaningful that physicians and physicists have led the way to proactively protect patients with an incident learning system," said Rep. Pallone.

Rep. Whitfield added, "I am pleased that ASTRO and AAPM have partnered to tackle the important task of improving the safety and quality of radiation therapy treatments, thereby advancing radiation oncology care for our nation's cancer patients."

AHRQ's Dr. Brady noted the importance of learning from near misses and adverse events. "Patient safety events are often too rare for a facility to identify causal factors with certainty," he said. "Each provider benefits from the insights that it can obtain from PSOs that aggregate large volumes of event data from multiple providers." The PSO program continues to grow, with 80 PSOs currently listed in 29 states and the District of Columbia, according to the AHRQ PSO website, http://www.pso.ahrq.gov/.

RO-ILS is a key milestone in ASTRO's Target Safely campaign, a patient protection plan to improve safety and quality for radiation oncology. PSOs, established by the Patient Safety and Quality Improvement Act of 2005 (PSQIA), facilitate the reporting and analysis of safety events by offering legal and confidentiality protections to U.S.-based practices. ASTRO has contracted with Clarity PSO, one of the earliest organizations to be federally qualified as a PSO, to build the online interface and to provide the affiliated patient safety services outlined in PSQIA.

RO-ILS began with an initial testing and evaluation period in September 2013 with a select number of testing sites who have served as early adopters of the system. The early adopters include a variety of practice settings located across the country: large academic centers, community hospitals and freestanding clinics. In order to ensure a comprehensive assessment of the program, early adopters experienced the full participation processfrom signing the necessary contract with Clarity PSO to RO-ILS training, data submission and analysis.

RO-ILS also includes a Practice Quality Improvement (PQI) template as a free companion to the RO-ILS portal. The RO-ILS PQI template is qualified for physicians and physicists by the American Board of Radiology (ABR) in meeting the criteria for practice quality improvement, toward the purpose of fulfilling requirements in the ABR Maintenance of Certification Program. As a PQI project, radiation oncology practices participating in RO-ILS will complete two consecutive cycles of the four-part Plan-Do-Study-Act (PDSA) process for quality improvement using the RO-ILS online portal to submit and internally track events. The first PDSA cycle will help radiation oncology practices to set baseline data, to evaluate their performance and to develop a quality improvement plan. The second PDSA cycle will remeasure their performance with regard to this quality improvement plan and assess whether the goals have been achieved.

Clarity PSO is a division of Clarity Group, Inc., a healthcare professional liability risk management organization. Neither Clarity PSO nor Clarity Group, Inc. is affiliated with ASTRO; they are independent entities providing PSO services to the radiation oncology practices enrolled in RO-ILS.

Detailed information about RO-ILS and participation forms are available at http://www.astro.org/ROILS.


'/>"/>

Contact: Michelle Kirkwood
michellek@astro.org
703-286-1600
American Society for Radiation Oncology
Source:Eurekalert

Related medicine news :

1. Antibody therapy prevents gastrointestinal damage following radiation exposure in mice
2. Diagnostic Scans Tied to Radiation Risk for Gastro Patients
3. Gastro Woes Often Strike Rheumatoid Arthritis Patients
4. Not taking gastroprotective drugs prescribed with anti-inflammatory medicines
5. Football-related catastrophic brain injuries on the rise
6. Catastrophic Head Injuries to High School Football Players Rising
7. Gastroenterology special issue focuses on new directions of viral hepatitis care and research
8. Gastroenterology Societies issue sedation curriculum for gastrointestinal endoscopy
9. ASTRO wins 2012 Communicator Award
10. ASTRO chairman to testify at CARE Act hearing
11. IU gastroenterologist develops practice guidelines for most prevalent liver disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... , ... June 25, 2016 , ... Austin residents seeking ... American College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical ... effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by ...
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding ... of its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. ... James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. ...
(Date:6/25/2016)... , ... June 25, 2016 , ... On Friday, June ... a Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments ... of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set ... drug or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, ... traumatic event. , Trauma sufferers tend to feel a range of emotions, from depression, ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Scientific Sessions in Dallas that it will receive two significant new grants to ... came as PHA marked its 25th anniversary by recognizing patients, medical professionals and ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Dehaier Medical Systems Ltd. (NASDAQ: ... and sells medical devices and wearable sleep respiratory products ... cooperation agreement with Hongyuan Supply Chain Management Co., Ltd. ... 20, 2016, to develop Dehaier,s new Internet medical technology ... will leverage Hongyuan Supply Chain,s sales platform to reach ...
(Date:6/24/2016)... Belgium , June 24, 2016 ... today announced the appointment of Dr. Edward ... as a Non-Executive Director, effective June 23, 2016.Dr. ... Compensation and Nominations and Governance Committees.  As a ... will provide independent expertise and strategic counsel to ...
(Date:6/23/2016)... Research and Markets has announced the addition ... Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, Binder, ... Forecast to 2021" report to their offering. ... excipients market is projected to reach USD 8.1 Billion ... forecast period 2016 to 2021. The ...
Breaking Medicine Technology: